Assessing Operation Warp Speed: What’s working, what’s not

Print Friendly, PDF & Email
f b b bb c df f
Credit: Shealah Craighead/White House

Is [Operation Warp Speed] working?

Roughly five months after top U.S. health officials coalesced around the idea of a public-private effort to accelerate the development, manufacturing, and distribution of Covid-19 vaccines, therapeutics, and diagnostics, an answer to that question remains out of reach. But with billions of federal dollars already spent on the effort, it’s possible to take stock of the initiative’s progress, or lack thereof.

Here’s an assessment of the work so far.

If all goes well, the fast-tracking of vaccine development, which normally takes years, will have been telescoped down to about a year. To date, the fastest a vaccine was ever developed was four years.

Operation Warp Speed, or OWS, has already spent about $10 billion.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Basic questions about what is being done and why are often not laid out. It’s not crystal clear, for instance, why OWS picked the vaccine projects to fund that it did, or how the process was handled.

Related article:  Life with the pandemic: 4 ways our bodies might respond to new COVID waves

The trial protocols for the studies, which would explain what and how analyses are being done, have not been published. However, for the trial of Moderna’s vaccine, data on the diversity of the participants are being regularly made public.

Key public health professionals across the country have been in the dark about how Covid-19 vaccines, once available, will be distributed and administered.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists